Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

SPRYSPRY
22 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in ARS PHARMACEUTICALS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 551,416 shares of SPRY (ARS PHARMACEUTICALS INC), worth $4.4M as of 2026-Q2. The position was increased (+3.4% shares). SPRY represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$4.4M

Current Shares

551,416

Total Value Change

+$733,842

Total Shares Change

+467,003

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
551,416
+3.4%
$4.4M0.0%$8.01
28
2026-Q1
Decreased
533,394
-3.2%
$4.3M0.0%$8.87
0
2025-Q4
Increased
550,932
+5.8%
$6.4M0.0%$11.64
29
2025-Q3
Increased
520,758
+17.8%
$5.2M0.0%$9.72
32
2025-Q2
Increased
442,202
+6.1%
$7.7M0.0%$18.20
29
2025-Q1
Decreased
416,657
-2.5%
$5.2M0.0%$12.49
0
2024-Q4
Increased
427,477
+0.8%
$4.5M0.0%$10.62
27
2024-Q3
Increased
423,947
+2.0%
$6.1M0.0%$14.32
28
2024-Q2
Increased
415,530
+20.3%
$3.5M0.0%$8.51
32
2024-Q1
Increased
345,295
+4.8%
$3.5M0.0%$10.22
28
2023-Q4
Increased
329,550
+1.6%
$1.8M0.0%$5.48
26
2023-Q3
Increased
324,403
+353.0%
$1.2M0.0%$3.78
41
2023-Q2
Increased
71,611
+342.9%
$479,7940.0%$6.61
39
2023-Q1
Unchanged
16,170
0.0%
$105,2670.0%$6.73
0
2022-Q4
New
16,170
-
$137,9300.0%$8.53
34
2022-Q3
Exited
0
-100.0%
$00.0%$5.29
0
2022-Q2
Decreased
106,414
-27.8%
$452,0000.0%$4.41
0
2022-Q1
Decreased
147,375
-1.1%
$518,0000.0%$3.52
0
2021-Q4
Increased
148,943
+7.1%
$992,0000.0%$6.60
27
2021-Q3
Increased
139,105
+62.1%
$1.4M0.0%$10.55
37
2021-Q2
Increased
85,804
+1.6%
$2.7M0.0%$31.54
27
2021-Q1
New
84,413
-
$3.7M0.0%$40.57
37

Other major holders of SPRY: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used